These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 20482672)

  • 1. The embryonic morphogen, Nodal, is associated with channel-like structures in human malignant melanoma xenografts.
    McAllister JC; Zhan Q; Weishaupt C; Hsu MY; Murphy GF
    J Cutan Pathol; 2010 Apr; 37 Suppl 1(Suppl 1):19-25. PubMed ID: 20482672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Divergence(s) in nodal signaling between aggressive melanoma and embryonic stem cells.
    Khalkhali-Ellis Z; Kirschmann DA; Seftor EA; Gilgur A; Bodenstine TM; Hinck AP; Hendrix MJ
    Int J Cancer; 2015 Mar; 136(5):E242-51. PubMed ID: 25204799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting Syndecan-1, a molecule implicated in the process of vasculogenic mimicry, enhances the therapeutic efficacy of the L19-IL2 immunocytokine in human melanoma xenografts.
    Orecchia P; Conte R; Balza E; Pietra G; Mingari MC; Carnemolla B
    Oncotarget; 2015 Nov; 6(35):37426-42. PubMed ID: 26460958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of the embryonic morphogen Nodal by Notch4 facilitates manifestation of the aggressive melanoma phenotype.
    Hardy KM; Kirschmann DA; Seftor EA; Margaryan NV; Postovit LM; Strizzi L; Hendrix MJ
    Cancer Res; 2010 Dec; 70(24):10340-50. PubMed ID: 21159651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Merkel cell carcinoma expresses vasculogenic mimicry: demonstration in patients and experimental manipulation in xenografts.
    Lezcano C; Kleffel S; Lee N; Larson AR; Zhan Q; DoRosario A; Wang LC; Schatton T; Murphy GF
    Lab Invest; 2014 Oct; 94(10):1092-102. PubMed ID: 25111691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rictor regulates the vasculogenic mimicry of melanoma via the AKT-MMP-2/9 pathway.
    Liang X; Sun R; Zhao X; Zhang Y; Gu Q; Dong X; Zhang D; Sun J; Sun B
    J Cell Mol Med; 2017 Dec; 21(12):3579-3591. PubMed ID: 28699701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melanoma spheroid formation involves laminin-associated vasculogenic mimicry.
    Larson AR; Lee CW; Lezcano C; Zhan Q; Huang J; Fischer AH; Murphy GF
    Am J Pathol; 2014 Jan; 184(1):71-8. PubMed ID: 24332013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VEGFR-1 expressed by malignant melanoma-initiating cells is required for tumor growth.
    Frank NY; Schatton T; Kim S; Zhan Q; Wilson BJ; Ma J; Saab KR; Osherov V; Widlund HR; Gasser M; Waaga-Gasser AM; Kupper TS; Murphy GF; Frank MH
    Cancer Res; 2011 Feb; 71(4):1474-85. PubMed ID: 21212411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Embryonic morphogen nodal promotes breast cancer growth and progression.
    Quail DF; Zhang G; Walsh LA; Siegers GM; Dieters-Castator DZ; Findlay SD; Broughton H; Putman DM; Hess DA; Postovit LM
    PLoS One; 2012; 7(11):e48237. PubMed ID: 23144858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential role of tissue factor pathway inhibitors 1 and 2 in melanoma vasculogenic mimicry.
    Ruf W; Seftor EA; Petrovan RJ; Weiss RM; Gruman LM; Margaryan NV; Seftor RE; Miyagi Y; Hendrix MJ
    Cancer Res; 2003 Sep; 63(17):5381-9. PubMed ID: 14500372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of Vasculogenic Mimicry Overrides VEGF-A Silencing and Enriches Stem-like Cancer Cells in Melanoma.
    Schnegg CI; Yang MH; Ghosh SK; Hsu MY
    Cancer Res; 2015 Apr; 75(8):1682-90. PubMed ID: 25769726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the embryological morphogen Nodal in stage III/IV melanoma.
    Hooijkaas AI; Gadiot J; van Boven H; Blank C
    Melanoma Res; 2011 Dec; 21(6):491-501. PubMed ID: 22002671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nodal signaling promotes vasculogenic mimicry formation in breast cancer via the Smad2/3 pathway.
    Gong W; Sun B; Zhao X; Zhang D; Sun J; Liu T; Gu Q; Dong X; Liu F; Wang Y; Lin X; Li Y
    Oncotarget; 2016 Oct; 7(43):70152-70167. PubMed ID: 27659524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Embryonic and tumorigenic pathways converge via Nodal signaling: role in melanoma aggressiveness.
    Topczewska JM; Postovit LM; Margaryan NV; Sam A; Hess AR; Wheaton WW; Nickoloff BJ; Topczewski J; Hendrix MJ
    Nat Med; 2006 Aug; 12(8):925-32. PubMed ID: 16892036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor cell vascular mimicry: Novel targeting opportunity in melanoma.
    Hendrix MJ; Seftor EA; Seftor RE; Chao JT; Chien DS; Chu YW
    Pharmacol Ther; 2016 Mar; 159():83-92. PubMed ID: 26808163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression profiling of long noncoding RNAs associated with vasculogenic mimicry in osteosarcoma.
    Ren K; Ni Y; Li X; Wang C; Chang Q; Li Y; Gao Z; Wu S; Shi X; Song J; Yao N; Zhou J
    J Cell Biochem; 2019 Aug; 120(8):12473-12488. PubMed ID: 30825232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo apatinib inhibits vasculogenic mimicry in melanoma MUM-2B cells.
    Liu ZJ; Zhou YJ; Ding RL; Xie F; Fu SZ; Wu JB; Yang LL; Wen QL
    PLoS One; 2018; 13(7):e0200845. PubMed ID: 30052652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneous phenotype of human melanoma cells with in vitro and in vivo features of tumor-initiating cells.
    Perego M; Tortoreto M; Tragni G; Mariani L; Deho P; Carbone A; Santinami M; Patuzzo R; Mina PD; Villa A; Pratesi G; Cossa G; Perego P; Daidone MG; Alison MR; Parmiani G; Rivoltini L; Castelli C
    J Invest Dermatol; 2010 Jul; 130(7):1877-86. PubMed ID: 20376064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphologic research of microcirculation patterns in human and animal melanoma.
    Zhang S; Zhang D; Wang Y; Zhao W; Guo H; Zhao X; Sun B
    Med Oncol; 2006; 23(3):403-9. PubMed ID: 17018898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gallbladder cancer-associated fibroblasts promote vasculogenic mimicry formation and tumor growth in gallbladder cancer via upregulating the expression of NOX4, a poor prognosis factor, through IL-6-JAK-STAT3 signal pathway.
    Pan MS; Wang H; Ansari KH; Li XP; Sun W; Fan YZ
    J Exp Clin Cancer Res; 2020 Nov; 39(1):234. PubMed ID: 33153467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.